Excelfin Acquisition Corp. - XFINU STOCK NEWS

Welcome to our dedicated page for Excelfin Acquisition news (Ticker: XFINU), a resource for investors and traders seeking the latest updates and insights on Excelfin Acquisition stock.

ExcelFin Acquisition Corp. is a blank check company formed with the primary objective of executing a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. As a blank check company, ExcelFin Acquisition Corp. operates by raising funds from an initial public offering (IPO) without specifying the target business or industry for a merger. The company's latest news includes an announcement of the adjournment of the Special Meeting originally scheduled for October 18, 2023, to October 20, 2023, and further rescheduled to October 22, 2023. The Special Meeting will be exclusively conducted via live webcast, and the record date for stockholders remains September 22, 2023. Stockholders can vote at the Special Meeting even if they have sold their shares after the record date. The company has extended the deadline for the submission of shares for redemption until October 18, 2023. Investors and security holders are advised to read the definitive proxy statement and other relevant materials for detailed information about the company.

10/17/2023 05:20 PM

News

ExcelFin Acquisition Corp. Announces Adjournment of Special Meeting

Rhea-AI Summary

ExcelFin Acquisition Corp. announces adjournment of Special Meeting

Rhea-AI Impact

Rhea-AI Sentiment

End-of-Day

-8.07%

ExcelFin Acquisition Corp. Announces the Separate Trading of its Class A Common Stock and Warrants, Commencing December 13, 2021

Rhea-AI Summary

ExcelFin Acquisition Corp. (Nasdaq: XFIN) announced that as of December 13, 2021, holders of its initial public offering units can separately trade Class A common stock and warrants. The Class A common stock will trade under the ticker XFIN, while the warrants will trade under XFINW. Each unit consists of one share of Class A common stock and one-half of a redeemable warrant, with whole warrants exercisable at $11.50 per share. Units not separated will continue trading as XFINU.

Rhea-AI Impact

Rhea-AI Sentiment

End-of-Day

0.1%

ExcelFin Acquisition Corp. Announces Pricing of $200 Million Initial Public Offering

Rhea-AI Summary

ExcelFin Acquisition Corp. (NASDAQ: XFIN) has priced its initial public offering (IPO) at $10.00 per unit, totaling 20,000,000 units. Each unit comprises one share of Class A Common Stock and one-half of a redeemable warrant. The units are set to trade under the ticker symbol 'XFINU' starting from October 21, 2021. A 45-day option is available for underwriters to purchase an additional 3,000,000 units to cover over-allotments. The offering is anticipated to close on or about October 25, 2021.

Rhea-AI Impact

Rhea-AI Sentiment

End-of-Day

-- %

FAQ

What is ExcelFin Acquisition Corp.'s primary objective?

ExcelFin Acquisition Corp. is formed to carry out a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses.

What is the latest news about ExcelFin Acquisition Corp.?

The latest news includes the adjournment of the Special Meeting, originally scheduled for October 18, 2023, to October 20, 2023, and further rescheduled to October 22, 2023. Stockholders can vote at the meeting, even if they have sold their shares after the record date.

What is the record date for stockholders to vote at the Special Meeting?

The record date for stockholders to vote at the Special Meeting is September 22, 2023.

What action should stockholders who have previously submitted their proxy take?

Stockholders who have previously submitted their proxy or voted and do not want to change their vote need not take any action.

How can stockholders withdraw their previously submitted redemption request?

Stockholders wishing to withdraw their redemption request may do so by requesting that the transfer agent return their shares before the rescheduled meeting.

Where can investors and security holders obtain free copies of relevant documents about ExcelFin Acquisition Corp.?

Investors and security holders can access free copies of documents, including the definitive proxy statement and other materials, from the SEC's website or by contacting ExcelFin Acquisition Corp. directly.

Who are the participants in the solicitation of proxies from ExcelFin Acquisition Corp. stockholders?

Company's sponsor, officers, directors, and other associated parties may be deemed participants in the solicitation of proxies from ExcelFin Acquisition Corp. stockholders. Detailed information about the participants and their interests can be found in the proxy statement and SEC filings.

Is this press release a solicitation of proxies or an offer to buy securities?

No, this press release is not a proxy statement or solicitation of a proxy, consent, or authorization regarding any securities. It does not constitute an offer to sell or solicitation to buy securities.

How can shareholders contact ExcelFin Acquisition Corp.'s Investor Relations?

Shareholders can reach out to Robin Yang, Partner at ICR, LLC, by phone at +1 (646) 308-1475 or email at BairdMedical.IR@icrinc.com for Investor Relations inquiries.

Who should shareholders contact for Public Relations related to ExcelFin Acquisition Corp.?

Shareholders can contact Brad Burgess, Senior Vice President at ICR, LLC, by phone at +1 (646) 588-0383 or email at BairdMedical.PR@icrinc.com for Public Relations matters.

What is the source of this information about ExcelFin Acquisition Corp.?

The information about ExcelFin Acquisition Corp. is sourced directly from the company's announcements and press releases, including the latest news about the adjournment of the Special Meeting.